New Drug Approvals

APRIL 27, 2025

6] It was first approved in the US in 2004, and an extended release version was brought to market in 2007. 9] [10] [11] Pharmacokinetics After oral administration, less than 10% of the dose is absorbed. “Clinical pharmacokinetics of trospium chloride” Clin Pharmacokinet. billion in 2004. [23] 12 (6): 815827.

FDA Approval 57

FDA Approval FDA Pharmacokinetics Licensing 57

New Drug Approvals

MAY 22, 2025

4] The co-packaged combination sulbactam/durlobactam was approved for medical use in the United States in May 2023. [5] 7] References ^ Totir MA, Helfand MS, Carey MP, Sheri A, Buynak JD, Bonomo RA, Carey PR (August 2007). 7] References ^ Totir MA, Helfand MS, Carey MP, Sheri A, Buynak JD, Bonomo RA, Carey PR (August 2007).

Pharmacokinetics 62

Pharmacokinetics FDA Production FDA Approval 62

Codon

FEBRUARY 23, 2025

Starting in 2007, a human trial in Ecuador and Peru found that this drug duo reduced HIV incidence by 44 percent among men who have sex with men; adherence issues likely prevented full protection. ” While most drugs enter the bloodstream faster than they are removed from the body, lenacapavir exhibits " flip flop kinetics " instead.

Clinical Trials 76

Clinical Trials Virus Vaccine DNA 76